Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 1999;19:625-632

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Barbagallo, C. M.
Right arrow Articles by Krauss, R. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barbagallo, C. M.
Right arrow Articles by Krauss, R. M.
Related Collections
Right arrow Biochemistry and metabolism
Right arrow Genetically altered mice
Right arrow Lipid and lipoprotein metabolism
(Arteriosclerosis, Thrombosis, and Vascular Biology. 1999;19:625-632.)
© 1999 American Heart Association, Inc.


Original Contributions

Overexpression of Human Hepatic Lipase and ApoE in Transgenic Rabbits Attenuates Response to Dietary Cholesterol and Alters Lipoprotein Subclass Distributions

Carlo M. Barbagallo; Jianglin Fan; Patricia J. Blanche; Manfredi Rizzo; John M. Taylor; Ronald M. Krauss

From the Istituto di Medicina Interna e Geriatria (C.M.B.), Universitá degli Studi di Palermo, Italy; the Gladstone Institute of Cardiovascular Disease (J.F., J.M.T.), University of California, San Francisco; and the Life Sciences Division (C.M.B., P.J.B., M.R., R.M.K.), Ernest Orlando Lawrence Berkeley National Laboratory, University of California, Berkeley.

Correspondence to Ronald M. Krauss, MD, Lawrence Berkeley National Laboratory, Donner Laboratory, Room 459, University of California, One Cyclotron Road, Berkeley, CA 94720. E-mail rmkrauss{at}lbl.gov

Abstract—The effect of the expression of human hepatic lipase (HL) or human apoE on plasma lipoproteins in transgenic rabbits in response to dietary cholesterol was compared with the response of nontransgenic control rabbits. Supplementation of a chow diet with 0.3% cholesterol and 3.0% soybean oil for 10 weeks resulted in markedly increased levels of plasma cholesterol and VLDL and IDL in control rabbits as expected. Expression of either HL or apoE reduced plasma cholesterol response by 75% and 60%, respectively. The HL transgenic rabbits had substantial reductions in medium and small VLDL and IDL fractions but not in larger VLDL. LDL levels were also reduced, with a shift from larger, more buoyant to smaller, denser particles. In contrast, apoE transgenic rabbits had a marked reduction in the levels of large VLDLs, with a selective accumulation of IDLs and large buoyant LDLs. Combined expression of apoE and HL led to dramatic reductions of total cholesterol (85% versus controls) and of total VLDL+IDL+LDL (87% versus controls). HDL subclasses were remodeled by the expression of either transgene and accompanied by a decrease in HDL cholesterol compared with controls. HL expression reduced all subclasses except for HDL2b and HDL2a, and expression of apoE reduced large HDL1 and HDL2b. Extreme HDL reductions (92% versus controls) were observed in the combined HL+apoE transgenic rabbits. These results demonstrate that human HL and apoE have complementary and synergistic functions in plasma cholesterol and lipoprotein metabolism.


Key Words: lipoproteins • apoE • hepatic lipase • rabbits • transgene




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
N. Grarup, C. H. Andreasen, M. K. Andersen, A. Albrechtsen, A. Sandbaek, T. Lauritzen, K. Borch-Johnsen, T. Jorgensen, O. Schmitz, T. Hansen, et al.
The -250G>A Promoter Variant in Hepatic Lipase Associates with Elevated Fasting Serum High-Density Lipoprotein Cholesterol Modulated by Interaction with Physical Activity in a Study of 16,156 Danish Subjects
J. Clin. Endocrinol. Metab., June 1, 2008; 93(6): 2294 - 2299.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
L. Freeman, M. J. A. Amar, R. Shamburek, B. Paigen, H. B. Brewer Jr., S. Santamarina-Fojo, and H. Gonzalez-Navarro
Lipolytic and ligand-binding functions of hepatic lipase protect against atherosclerosis in LDL receptor-deficient mice
J. Lipid Res., January 1, 2007; 48(1): 104 - 113.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Gonzalez-Navarro, Z. Nong, M. J. A. Amar, R. D. Shamburek, J. Najib-Fruchart, B. J. Paigen, H. B. Brewer Jr., and S. Santamarina-Fojo
The Ligand-binding Function of Hepatic Lipase Modulates the Development of Atherosclerosis in Transgenic Mice
J. Biol. Chem., October 29, 2004; 279(44): 45312 - 45321.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. Santamarina-Fojo, H. Gonzalez-Navarro, L. Freeman, E. Wagner, and Z. Nong
Hepatic Lipase, Lipoprotein Metabolism, and Atherogenesis
Arterioscler Thromb Vasc Biol, October 1, 2004; 24(10): 1750 - 1754.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
U. C. Broedl, C. Maugeais, J. S. Millar, W. Jin, R. E. Moore, I. V. Fuki, D. Marchadier, J. M. Glick, and D. J. Rader
Endothelial Lipase Promotes the Catabolism of ApoB-Containing Lipoproteins
Circ. Res., June 25, 2004; 94(12): 1554 - 1561.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Rizzo, J. M. Taylor, C. M. Barbagallo, K. Berneis, P. J. Blanche, and R. M. Krauss
Effects on Lipoprotein Subclasses of Combined Expression of Human Hepatic Lipase and Human apoB in Transgenic Rabbits
Arterioscler Thromb Vasc Biol, January 1, 2004; 24(1): 141 - 146.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
P. Kee, K.-A. Rye, J. L. Taylor, P. H. R. Barrett, and P. J. Barter
Metabolism of ApoA-I as Lipid-Free Protein or as Component of Discoidal and Spherical Reconstituted HDLs: Studies in Wild-Type and Hepatic Lipase Transgenic Rabbits
Arterioscler Thromb Vasc Biol, November 1, 2002; 22(11): 1912 - 1917.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
B. G. Brown, M. C. Cheung, A. C. Lee, X.-Q. Zhao, and A. Chait
Antioxidant Vitamins and Lipid Therapy: End of a Long Romance?
Arterioscler Thromb Vasc Biol, October 1, 2002; 22(10): 1535 - 1546.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
A. Zambon, S. S. Deeb, A. Bensadoun, K. E. Foster, and J. D. Brunzell
In vivo evidence of a role for hepatic lipase in human apoB-containing lipoprotein metabolism, independent of its lipolytic activity
J. Lipid Res., December 1, 2000; 41(12): 2094 - 2099.
[Abstract] [Full Text]